SYSTEMS FOR TARGETED THERAPEUTIC NASAL NEUROMODULATION
Patent Information
- Application Number
- DE602020049128
- Authority / Receiving Office
- DE · DE
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2019-06-28
- Filing Date
- 2020-06-29
- Publication Date
- 2025-04-09
- Estimated Expiration
- 2040-06-29
AI Technical Summary
Current surgical methods for treating rhinosinusitis cannot precisely target neural tissue in the nasal region, leading to significant collateral damage to surrounding non-neural tissue, such as blood vessels, during procedures like thermal energy delivery or microdebrider resection.
A system comprising a treatment device with a micro-electrode array and a controller that senses the presence and depth of neural tissue within the nasal anatomy, allowing for precise targeting and minimization of collateral damage by tuning micro-lesion depths and independently controlling energy delivery to individual electrodes.
The system enables precise and targeted modulation of neural tissue in the nasal region, minimizing damage to surrounding non-neural tissue, thereby effectively treating rhinosinusitis while reducing the risk of complications.